ワクチンアジュバントの世界市場2021-2026:経口、皮下、筋肉内、その他

LP Informationが発行した調査報告書(LPI21JL16873)
◆英語タイトル:Global Vaccine Adjuvants Market Growth 2021-2026
◆商品コード:LPI21JL16873
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:158
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「ワクチンアジュバントの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口、皮下、筋肉内、その他など、用途別には、獣医用ワクチンアジュバント(研究用、商用用)、ヒト用ワクチンアジュバント(研究用、商用用)などにセグメント区分してまとめました。ワクチンアジュバントのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ワクチンアジュバントの世界市場概要(サマリー)
・ワクチンアジュバントの企業別販売量・売上
・ワクチンアジュバントの企業別市場シェア
・ワクチンアジュバントの世界市場規模 2016年-2021年:種類別(経口、皮下、筋肉内、その他)
・ワクチンアジュバントの世界市場規模 2016年-2021年:用途別(獣医用ワクチンアジュバント(研究用、商用用)、ヒト用ワクチンアジュバント(研究用、商用用))
・ワクチンアジュバントの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ワクチンアジュバントのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ワクチンアジュバントのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ワクチンアジュバントの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ワクチンアジュバント市場の成長要因・課題・動向
・ワクチンアジュバントの世界市場予測 2021年-2026年
・ワクチンアジュバントの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ワクチンアジュバントのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ワクチンアジュバントのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ワクチンアジュバントの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ワクチンアジュバントの世界市場予測:種類別(経口、皮下、筋肉内、その他)
・ワクチンアジュバントの世界市場予測:用途別(獣医用ワクチンアジュバント(研究用、商用用)、ヒト用ワクチンアジュバント(研究用、商用用))
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Vaccine Adjuvants will have significant change from previous year. By the most conservative estimates of global Vaccine Adjuvants market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 745.4 million in 2020. Over the next five years the Vaccine Adjuvants market will register a 10.6% CAGR in terms of revenue, the global market size will reach US$ 1114.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral
Subcutaneous
Intramuscular
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Consumption 2016-2026
2.1.2 Vaccine Adjuvants Consumption CAGR by Region
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Vaccine Adjuvants Sales by Type
2.3.1 Global Vaccine Adjuvants Sales Market Share by Type (2016-2021)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2016-2021)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2016-2021)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
2.4.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
2.5 Vaccine Adjuvants Sales by Application
2.5.1 Global Vaccine Adjuvants Sale Market Share by Application (2016-2021)
2.5.2 Global Vaccine Adjuvants Revenue and Market Share by Application (2016-2021)
2.5.3 Global Vaccine Adjuvants Sale Price by Application (2016-2021)

3 Global Vaccine Adjuvants by Company
3.1 Global Vaccine Adjuvants Sales Market Share by Company
3.1.1 Global Vaccine Adjuvants Sales by Company (2019-2021)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2019-2021)
3.2 Global Vaccine Adjuvants Revenue Market Share by Company
3.2.1 Global Vaccine Adjuvants Revenue by Company (2019-2021)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2019-2021)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Global Manufacturers Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Adjuvants Product Location Distribution
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vaccine Adjuvants by Region
4.1 Global Vaccine Adjuvants by Region
4.1.1 Global Vaccine Adjuvants Sales by Region
4.1.2 Global Vaccine Adjuvants Revenue by Region
4.2 Americas Vaccine Adjuvants Sales Growth
4.3 APAC Vaccine Adjuvants Sales Growth
4.4 Europe Vaccine Adjuvants Sales Growth
4.5 Middle East & Africa Vaccine Adjuvants Sales Growth

5 Americas
5.1 Americas Vaccine Adjuvants Sales by Country
5.1.1 Americas Vaccine Adjuvants Sales by Country (2016-2021)
5.1.2 Americas Vaccine Adjuvants Revenue by Country (2016-2021)
5.2 Americas Vaccine Adjuvants Sales by Type
5.3 Americas Vaccine Adjuvants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Vaccine Adjuvants Sales by Region
6.1.1 APAC Vaccine Adjuvants Sales by Region (2016-2021)
6.1.2 APAC Vaccine Adjuvants Revenue by Region (2016-2021)
6.2 APAC Vaccine Adjuvants Sales by Type
6.3 APAC Vaccine Adjuvants Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Vaccine Adjuvants by Country
7.1.1 Europe Vaccine Adjuvants Sales by Country (2016-2021)
7.1.2 Europe Vaccine Adjuvants Revenue by Country (2016-2021)
7.2 Europe Vaccine Adjuvants Sales by Type
7.3 Europe Vaccine Adjuvants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Vaccine Adjuvants Sales by Country (2016-2021)
8.1.2 Middle East & Africa Vaccine Adjuvants Revenue by Country (2016-2021)
8.2 Middle East & Africa Vaccine Adjuvants Sales by Type
8.3 Middle East & Africa Vaccine Adjuvants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine Adjuvants Distributors
10.3 Vaccine Adjuvants Customer

11 Global Vaccine Adjuvants Market Forecast
11.1 Global Vaccine Adjuvants Forecast by Region
11.1.1 Global Vaccine Adjuvants Forecast by Regions (2021-2026)
11.2.2 Global Vaccine Adjuvants Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Vaccine Adjuvants Forecast by Type
11.7 Global Vaccine Adjuvants Forecast by Application

12 Key Players Analysis
12.1 SEPPIC
12.1.1 SEPPIC Company Information
12.1.2 SEPPIC Vaccine Adjuvants Product Offered
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 SEPPIC Main Business Overview
12.1.5 SEPPIC Latest Developments
12.2 SDA BIO
12.2.1 SDA BIO Company Information
12.2.2 SDA BIO Vaccine Adjuvants Product Offered
12.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 SDA BIO Main Business Overview
12.2.5 SDA BIO Latest Developments
12.3 Croda International Plc
12.3.1 Croda International Plc Company Information
12.3.2 Croda International Plc Vaccine Adjuvants Product Offered
12.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Croda International Plc Main Business Overview
12.3.5 Croda International Plc Latest Developments
12.4 SPI Pharma
12.4.1 SPI Pharma Company Information
12.4.2 SPI Pharma Vaccine Adjuvants Product Offered
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 SPI Pharma Main Business Overview
12.4.5 SPI Pharma Latest Developments
12.5 Phibro Animal Health Corporation
12.5.1 Phibro Animal Health Corporation Company Information
12.5.2 Phibro Animal Health Corporation Vaccine Adjuvants Product Offered
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Phibro Animal Health Corporation Main Business Overview
12.5.5 Phibro Animal Health Corporation Latest Developments
12.6 Tj Kaiwei
12.6.1 Tj Kaiwei Company Information
12.6.2 Tj Kaiwei Vaccine Adjuvants Product Offered
12.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Tj Kaiwei Main Business Overview
12.6.5 Tj Kaiwei Latest Developments
12.7 Novavax
12.7.1 Novavax Company Information
12.7.2 Novavax Vaccine Adjuvants Product Offered
12.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novavax Main Business Overview
12.7.5 Novavax Latest Developments
12.8 Zhuoyue
12.8.1 Zhuoyue Company Information
12.8.2 Zhuoyue Vaccine Adjuvants Product Offered
12.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Zhuoyue Main Business Overview
12.8.5 Zhuoyue Latest Developments
12.9 Aphios
12.9.1 Aphios Company Information
12.9.2 Aphios Vaccine Adjuvants Product Offered
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Aphios Main Business Overview
12.9.5 Aphios Latest Developments
12.10 GSK
12.10.1 GSK Company Information
12.10.2 GSK Vaccine Adjuvants Product Offered
12.10.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GSK Main Business Overview
12.10.5 GSK Latest Developments
12.11 CSL Limited
12.11.1 CSL Limited Company Information
12.11.2 CSL Limited Vaccine Adjuvants Product Offered
12.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 CSL Limited Main Business Overview
12.11.5 CSL Limited Latest Developments
12.12 Brenntag Biosector
12.12.1 Brenntag Biosector Company Information
12.12.2 Brenntag Biosector Vaccine Adjuvants Product Offered
12.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Brenntag Biosector Main Business Overview
12.12.5 Brenntag Biosector Latest Developments
12.13 SEPPIC
12.13.1 SEPPIC Company Information
12.13.2 SEPPIC Vaccine Adjuvants Product Offered
12.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 SEPPIC Main Business Overview
12.13.5 SEPPIC Latest Developments
12.14 SPI Pharma
12.14.1 SPI Pharma Company Information
12.14.2 SPI Pharma Vaccine Adjuvants Product Offered
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 SPI Pharma Main Business Overview
12.14.5 SPI Pharma Latest Developments
12.15 Novavax
12.15.1 Novavax Company Information
12.15.2 Novavax Vaccine Adjuvants Product Offered
12.15.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Novavax Main Business Overview
12.15.5 Novavax Latest Developments
12.16 Avanti Polar Lipids
12.16.1 Avanti Polar Lipids Company Information
12.16.2 Avanti Polar Lipids Vaccine Adjuvants Product Offered
12.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Avanti Polar Lipids Main Business Overview
12.16.5 Avanti Polar Lipids Latest Developments
12.17 Aphios
12.17.1 Aphios Company Information
12.17.2 Aphios Vaccine Adjuvants Product Offered
12.17.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Aphios Main Business Overview
12.17.5 Aphios Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ワクチンアジュバントの世界市場2021-2026:経口、皮下、筋肉内、その他(Global Vaccine Adjuvants Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。